Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
OSPN heads into its October 29 earnings report with short sellers having added meaningfully over the past month, even as the stock itself has ground higher.
Short interest is the dominant story in this week's data, and the tension is stark. Bears have added roughly 28% more short exposure over the past 30 days, lifting the position to 11.1% of the free float, a level ORTEX classifies as high. Yet the stock has risen 10% over the same period, closing at $18.38 on Tuesday and gaining 3.1% on the week. That divergence, shorts rebuilding while price climbs, is the central setup heading into the Q3 print. The week-on-week move in short interest is modest, down just 0.5%, suggesting the buildup has broadly plateaued rather than accelerated into the report.
The lending market does not yet reflect urgency on either side. Borrow costs have eased roughly 13% over the week to 0.44%, a low rate that suggests no scramble to source shares. Availability is genuinely loose at 560% of short interest, meaning there are roughly 30.5 million shares available to borrow against 4.2 million already short. That availability figure is well off its 52-week low of 472% and nowhere near territory that would signal a squeeze setup. Options traders are similarly calm: the put/call ratio sits at 0.011, below its 20-day average of 0.016 and showing a slight bearish lean, but a z-score of minus 0.72 puts this well within normal range. Neither the borrow market nor options are amplifying the short-side thesis at this point.
The Street picture is a study in a split opinion that has not changed much in months. The most recent analyst moves came in August, when both active houses raised their targets after Q2 results: Rosenblatt lifted to $18 (Buy) and DA Davidson moved to $16 (Neutral). With the stock now at $18.38, it has run through the consensus mean target of $18, which makes the risk/reward arithmetic less compelling for fresh buyers. B. Riley carries a $23 target with a Buy, initiated in August 2025, which would represent the bull case ceiling. The bear case, set out by Benzinga's analysis, centres on cash consumption: $18.5M in buybacks, $14.3M in dividends and $34.6M for the Build38 acquisition have reduced the company's cash cushion to roughly $49.8M from $92.9M in mid-2025. That leaves less room for further capital returns or acquisitions to sustain momentum. The EV/EBITDA multiple runs at 8.6x, drifting slightly lower over the past 30 days, while PE has expanded to 14.2x. The ORTEX short score of 63.4 has drifted down from 64.3 over the past two weeks, a mild but steady easing.
Institutional ownership is broadly stable. BlackRock holds 10.2% as the largest shareholder, with a modest 44,000-share addition in its most recent filing. Dimensional added over 265,000 shares in the quarter. LSV added 659,000 shares, the largest disclosed addition in the table. None of the 13D/G filings on record carry activist intent: all are passive 13G holders, and the activist register shows no 13D filer. Legal and General has trimmed from 5.79% to 5.31%, and several other passive names have drifted below the 5% threshold entirely, including Ameriprise (now 0.3%) and Vanguard's pooled vehicle. Insider activity in September was limited to compensation mechanics: the CFO and CEO both exercised options and withheld shares for tax, with no open-market purchases or sales beyond the CFO's $289,000 open-market sale in June. That sale is the only discretionary insider move in the 90-day window.
The recent earnings history offers a narrow reference point. The most recent Q2 print in August produced a 2.7% one-day move higher. The Q1 print in June produced a 3.7% decline. Neither move is large, but with the stock already trading at or through analyst targets, the asymmetry on a miss may be more pronounced than usual.
With Q3 results due on October 29 and the stock sitting precisely at consensus price target, the next three weeks pivot almost entirely on whether earnings give the Street reason to move those targets higher again.
See the live data behind this article on ORTEX.
Open OSPN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
